# Project Proposal: In Silico Exploration of Non-Pluripotent Cellular Rejuvenation via Reinforcement Learning

## I. Executive Summary

This project explores a critical bottleneck in longevity medicine: **resetting the cellular aging clock without inducing pluripotency**, which carries significant tumorigenic risks. While Dr. Jean-Marc Lemaitre has demonstrated that aging is reversible even in centenarians, the transition from "global reprogramming" to safe, clinical "partial rejuvenation" remains complex due to the high-dimensional nature of gene interactions.

I propose a computational framework using **Reinforcement Learning (RL)** to identify optimal, non-linear induction schedules for transcription factors. By using foundation models like **Geneformer** as a virtual environment, I will train an RL agent to discover "safe paths" that maximize epigenetic rejuvenation while strictly avoiding the pluripotency manifold.

-----

## II. Scientific Context & Problem

Current cellular reprogramming relies primarily on Yamanaka factors (OSKM) to reset identity to an embryonic state. However, Dr. Lemaitre’s research poses a fundamental question: *"Is pluripotency necessary to rejuvenate an aging cell?"* (Lemaitre, 2026).

### Primary Barriers

1.  **Safety:** Full reprogramming risks dedifferentiation and teratoma formation.
2.  **Efficiency:** Standard 4-factor protocols often fail in senescent cells, requiring precise timing difficult to discover via traditional "wet-lab" trial and error.

**Key References:**

  * *Lapasset et al. (2011)* - Rejuvenating senescent and centenarian cells.
  * *Olova et al. (2019)* - Partial reprogramming strategies.
  * *Lemaitre (2026)* - Bypassing the pluripotent stage for healthy aging.

-----

## III. Objectives

1.  **Map the "Aging Manifold":** Visualize the transcriptomic path between old and young states.
2.  **Build Virtual Simulation:** Create an environment to test genetic perturbations *in silico*.
3.  **Optimize RL Agent:** Find trajectories that maximize "Age Reset" while minimizing "Identity Loss."

-----

## IV. Methodology & Technical Approach

1.  **Data Foundation:** Utilizing Solé-Boldo (2020) and Zou (2021) human skin fibroblast datasets.
2.  **Manifold Learning:** A **Variational Autoencoder (VAE)** built in TensorFlow to compress high-dimensional data into a latent manifold.
3.  **Simulation Environment:** Utilizing **Geneformer** (transformer-based foundation model) to predict cellular movement in response to gene activations.
4.  **RL Agent:** Implementing a **Deep Q-Network (DQN)**.
      * *Reward Function:* $R = w_1(\Delta(t\text{-Age})) - w_2(\text{Pluripotency Markers})$
5.  **Risk Mitigation:** Benchmarking simulation fidelity against known lab data.

-----

## V. Deliverables & Timeline

  - [ ] **Aging Manifold Map:** VAE-based visualization of fibroblast senescence paths. (Month 4)
  - [ ] **In Silico Trajectories:** RL-discovered schedules for safe rejuvenation. (Month 5)
  - [ ] **Comparative Analysis:** Evaluation of early-life vs. late-life intervention efficiency. (Month 5)
  - [ ] **Protocol Ranking:** List of candidate "Master Gene" protocols for lab validation. (Month 6)
